These results do not support the association hypothesis of significant risk of heterozygous ICAM1 genotype (241Gly/Arg) in GBS as it was raised in a previous control case study in India with GBS (Table 5). The gene discussed is ICAM1; the disease is Guillain-Barre syndrome.